How galenical development consulting enhances drug efficacy and safety
Galenical development consulting has become a strategic ally for laboratories and pharmaceutical companies. Its role spans from early-stage research to drug commercialization, ensuring that each phase meets international standards for efficacy, safety, and quality.
The value of galenical consulting
Galenics is the branch of pharmacy dedicated to transforming active pharmaceutical ingredients into safe and effective dosage forms. Capsules, tablets, liquid solutions, or transdermal systems are outcomes of this work.
Pharmaceutical galenical consulting brings specialized expertise to optimize resources and shorten development timelines—without compromising regulatory standards or the quality of the final product.
Key benefits
- Optimization of formulations to improve bioavailability and stability.
- Ensuring regulatory compliance with agencies such as the EMA or FDA.
- Support in process validation and industrial scale-up.
- Agile adaptation to regulatory changes and market demands.
Strategic consulting at every stage of the drug lifecycle
Research and development
In this initial phase, consulting services evaluate the solubility, stability, and technical feasibility of compounds. This enables informed decision-making that helps reduce costs and risks in later stages.
Clinical trials and pilot production
During clinical trials, the designed dosage form is crucial for generating reliable data. Consulting teams assist in the manufacturing of pilot batches, process validation, and scale-up, ensuring consistency from lab to plant.
Commercialization and post-marketing support
Once on the market, galenical consulting continues to offer strategic support. From long-term studies to process redesign, these services enhance patient acceptance and help maintain regulatory compliance.
Innovation and market differentiation
In a highly competitive sector, galenical development consulting drives innovation through the creation of new drug delivery systems, such as extended-release formulations or nanoparticles. These solutions improve treatment adherence and offer competitive advantages over existing products.
